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Abstract
Although Cystic fibrosis transmembrane conductance regulator (CFTR) has been shown to regulate the
activity of NHE3, the potential reciprocal interaction of NHE3 to modulate the protein kinase A
(PKA)-dependent regulation of CFTR in epithelial cells is still unknown. In the present work, we
describe experiments to define the interactions between CFTR and NHE3 with the regulatory,
scaffolding protein, NHERF that organize their PKA-dependent regulation in a renal epithelial cell line
that expresses endogenous CFTR. The expression of rat NHE3 significantly decreased PKA-dependent
activation of CFTR without altering CFTR expression, and this decrease was prevented by mutation of
either of the two rat NHE3 PKA target serines to alanine (S552A or S605A). Inhibition of CFTR
expression by antisense treatment resulted in an acute decrease in PKA-dependent regulation of NHE3
activity. CFTR, NHE3, and ezrin were recognized by NHERF-2 but not NHERF-1 in glutathione
S-transferase pull-down experiments. Ezrin may function as a protein kinase A anchoring protein
(AKAP) in this signaling complex, because blocking the binding of PKA to an AKAP by incubation
with the S-Ht31 peptide inhibited the PKA-dependent regulation of CFTR in the absence of NHE3. In
the A6-NHE3 cells S-Ht31 blocked the PKA regulation of NHE3 whereas it now failed to affect the
regulation of CFTR. We conclude that CFTR and NHE3 reciprocally interact via a shared regulatory
complex comprised of NHERF-2, ezrin, and PKA.
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Although CFTR has been shown to regulate the activity of NHE3, the potential reciprocal
interaction of NHE3 to modulate the PKA-dependent regulation of CFTR in epithelial cells is still
unknown. In the present work, we describe experiments to define the interactions between CFTR and
NHE3 with the regulatory, scaffolding protein, NHERF that organize their PKA-dependent regulation
in a renal epithelial cell line that expresses endogenous CFTR. The expression of rat NHE3
significantly decreased PKA-dependent activation of CFTR without altering CFTR expression and this
decrease was prevented by mutation of either of the two rat NHE3 PKA target serines to alanine
(S552A or S605A). Inhibition of CFTR expression by antisense treatment resulted in an acute decrease
in PKA-dependent regulation of NHE3 activity. CFTR, NHE3 and ezrin were recognized by NHERF-
2 but not NHERF-1 in GST pull-down experiments. Ezrin may function as a protein kinase A
anchoring protein (AKAP) in this signaling complex since blocking the binding of PKA to an AKAP
by incubation with the S-Ht31 peptide inhibited the PKA-dependent regulation of CFTR in the
absence of NHE3. In the A6-NHE3 cells S-Ht31 blocked the PKA regulation of NHE3 while it now
failed to affect the regulation of CFTR. We conclude that CFTR and NHE3 reciprocally interact via a
shared regulatory complex comprised of NHERF-2, ezrin and PKA.
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Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP activated Cl- channel
expressed in the luminal membrane of secretory and reabsorptive epithelia (1). In addition to
transepithelial chloride transport, CFTR has been shown to influence a large number of cell functions
including ion transporters such as outwardly rectifying chloride channels, amiloride-sensitive epithelial
sodium channels and renal outer medullary potassium channels  (2). Initial hypotheses concerning
CFTR function suggested that it may function primarily as a global conductance regulator thus
magnifying its role in normal cell function (3). Accordingly, defects in CFTR causing the disease cystic
fibrosis (CF) lead not only to disturbances of chloride secretion but also of the transport of other
electrolytes. In this context, CFTR has been demonstrated to affect both intracelluar and extracellular
pH regulation by alterations in either HCO3- secretion via activation and increased expression of the
Cl-/HCO3- antiporter (4,5) or by alterations in Na+/H+ exchanger (NHE) activity (6,7). 
The mechanisms by which CFTR exerts its regulatory role over other epithelial ion transporters
is still incompletely understood although several hypotheses are currently being explored. These
include indirect regulation via release of ATP through CFTR with a subsequent autocrine activation of
luminal purinoceptors and modulation of intracellular calcium which in turn could regulate other
transporters (8,9). Another regulatory mechanism involves direct intramembrane or cytoplasmic
protein-protein interaction. PDZ domain proteins are emerging as important organizing centers for
these regulatory complexes and these scaffold-based regulatory proteins are localized to specific sites
in polarized epithelial cells. It has been shown that the PKA-dependent regulation of the NHE isoform
located in the apical membrane (NHE3) is mediated via the scaffolding protein, NHE-Regulatory
Factor (NHERF), whose PDZ2 domain interacts with the cytoplasmic end of NHE3 (10,11). In vitro
binding studies have demonstrated that CFTR can bind to the PDZ1 domain of the NHERF with an
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intracellular C-terminal domain ending in D-S/T-x-L (12-14) providing a potential mechanism for
the CFTR modulation of the regulation of other membrane proteins such as the NHE3. Recently, using
CFTR and NHE3 cotransfection in fibroblasts, it was demonstrated that CFTR modifies the PKA-
dependent regulation of NHE3 via interaction with the NHERF-1 isoform (7). While some aspects of
the mechanism underlying the CFTR-dependent modulation of NHE3 have been established, the
existence of the potential reciprocal modulation of PKA-dependent regulation of CFTR by NHE3
remains undescribed. Further, as recently discussed (15) the results of many of the studies on regulation
of CFTR have been conducted in non-polarized cells and/or by over-expression of CFTR and, as such,
it may be difficult to draw conclusions about the regulation of CFTR during normal epithelial cell
function. 
The objective of the present work was to elucidate the dynamics and mechanism(s) of the
reciprocal alteration of PKA-dependent regulation of CFTR and NHE3 in epithelial cells. To establish
a working model of the dynamic interactions in a polarized epithelial cell, we have used an epithelial
renal cell line, A6, which when grown on permeable filters forms polarized monolayers with a high
transepithelial resistance, an amiloride sensitive sodium transport (16-18), and that also endogenously
expresses wild-type CFTR (19). We have transfected this cell line with: 1) the rat NHE3 (A6-NHE3)
which is functionally expressed on the apical membrane and displays the PKA and PKC regulatory
pattern charateristic for this isoform when endogenously expressed in epithelial cells (20); 2) antisense
oligonucleotides to suppress, transiently, CFTR expression and 3) two mutants of rat NHE3 in which
the PKA target serines 552 or 605 have been mutated to alanine. Using these epithelial cell lines, we
show that 1) the expression of CFTR is necessary for the PKA-dependent regulation of NHE3 while 2)
the expression of NHE3 reduces the PKA-dependent regulation of CFTR; 3) mutation of the PKA
substrate serines 552 or 605 of NHE3 relieves this repression of CFTR regulation; 4) both CFTR and
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NHE3 associate with the NHERF-2 and not the NHERF-1 isoform.  
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Experimental Procedures
Materials
All cell culture materials were purchased from Gibco. BCECF-AM (2’,7’-bis(carboxymethyl)-5(6)-
carboxyfluorescein-acetoxymethyl ester) and MQAE (N-[6-methoxyquinoly]acetoethyl ester) were
obtained from Molecular Probes. Glibenclamide and bumetanide were from Sigma. Hygromycin B and
nigericin were purchased from Calbiochem. All other chemicals and reagents used were from Sigma or
Fluka. 
Cell culture
A6/C1 cells used for transfection are a subclone of A6-2F3 cells, functionally selected on the basis of
high transepithelial resistance and resposiveness to aldosterone (21). Cell cultures are maintained in 0.8
x concentrated DMEM containing 25 mM NaHCO3, 10% heat-inactivated fetal bovine serum, 50
IU/ml penicillin and 50 mg/ml streptomycin for a final osmolarity of 220-250 mOsmol. Cells were
incubated in a humidified 95% air, 5% CO2 atmosphere at 28 °C and subcultured weekly by
trypsinization using a Ca2+/Mg2+-free salt solution containing 0.25% (w/v) trypsin and 1 mM EGTA.
These cells express endogenous basolateral Na/H exchange activity (22). Transfected cell lines were
generated by stable transfection in A6/C1 cells of the cDNAs encoding 1) full length (wild type)
 ratNHE3 (A6-NHE3), 2) ratNHE3 mutated at single endogenous serine position on the cytoplasmic tail of
NHE3 (A6-NHE3S552A and A6-NHE3S605A) and 3) full length OKNHE3 (NHE3 opossum
subtype) (A6-NHE3OK). All were subcloned into the pcDNA3.1 vector (Invitrogen, Groningen,
Nertherlands) as have been described previously (23). NHE3 constructs all contained a C-terminal
6
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 8, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
6His tag. For transfection, A6 cells were grown to 20-25% confluence in 35 mm tissue culture dishes
and DNA was introduced into cells plated on culture dishes using FuGENETM (Boehringher,
Mannheim, Germany) and 1.5 µg of the construct of interest together with 0.5 µg of the p3SSLacI
vector, which allowed us to select on the basis of hygromicin B resistance (450 µg ml-1 culture
medium, for details of the p3SSLacI construct see: (20)). Clonal populations of trasfected cell lines
obtained by ring cloning were maintaned as described above in hygromycin. Cells generally reached
confluency between 7 to 8 days after seeding when the culture medium was changed three times a
week. Studies on A6 cells were performed between passage 114 to 128. Experiments on A6-NHE3
cells were carried out on cells from passage 22 to 36 while those performed with the PKA deficient
mutants were carried out on cells from passage 34 to 38. 
Measurement of intracellular pH (pHi) and Na+/H+-exchange activity
For pH experiments, cells were seeded onto collagen-coated coverslips with a 1.5 mm hole
punched in the centre covered by a teflon filter (Millicell-CM, 0.4 µm pore size; Millipore) as
described (23). Cells were incubated for 60 min with 5 µM BCECF-AM in Na+-medium containing
50 µM probenecid to minimize possible dye leakage. Coverslips with filters containing confluent
monolayers were inserted into a chamber that allowed independent perfusion of the apical and
basolateral cell surface with Na+ medium and placed on the stage of an inverted  microscope (Zeiss IM
35). BCECF was excited sequentially by positioning 390-440 nm and 475-490 nm band pass filters in
front of a xenon lamp. The emission light was collected by a 515-565 nm band pass filter. pHi was
estimated from the ratio of BCECF fluorescence calibrated by using K+ nigericin approach (23).
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Na+/H+-exchange activity was measured by monitoring pHi recovery after an acid load by
using the NH4Cl prepulse technique (24). The rate of Na+-dependent alkalinization was determined by
linear regression analysis of 15 points taken at 4-sec intervals. The use of nominally CO2/HCO3- free
solutions minimizes the likelihood that Na+-dependent HCO3- transport was responsible for the
observed pHi changes.
Fluorescent measurements of apical chloride efflux
Chloride efflux was measured with the aid of the Cl- sensitive dye, MQAE, using the procedure
described before (25,26). In brief, A6 and A6-NHE3 cells were seeded onto collagen-coated cell
culture inserts having polyethylene terephthalate (PET) filters (Falcon Becton Dickinson). Monolayers
were loaded overnight in culture medium containing 5 mM MQAE at 28 °C in a CO2 incubator. After
several washes the filter containing the confluent monolayers were removed from the plastic insert and
inserted into a perfusion cuvette that allowed separate superfusion of apical and basolateral cell
surfaces (27). Fluorescence was recorded on a Shimadzu RF 5000 spectrofluorometer using 360 nm
(bandwidth 10 nm) as excitation wavelength and 450 nm (bandwidth 15 nm) as emission wavelength.
All chloride efflux experiments were performed at room temperature in HEPES-buffered
bicarbonate-free media (Cl- medium (in mM): NaCl 110, KCl 3, CaCl2 1, MgSO4 0.5, HEPES 10,
KH2PO4 1, glucose 5 and Cl- free medium: NaNO3 105, KNO3 3.2, MgSO4 0.8, NaH2PO4 1,
HEPES 10, CaNO3 5, glucose 5). At the start of the experiment the monolayers were perfused at a
constant rate of 2 ml/min in the Cl- medium. To measure the chloride efflux across the apical
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membrane, the apical Cl- perfusion medium was changed to the Cl- free medium and MQAE
fluorescence intensity followed. At the end of each experiment a two point calibration procedure was
performed: the maximal intensity of fluorescence (F0) was determinated by perfusing the cells with the
Cl- free medium on both sides of the monolayer; the minimal fluorescence was obtained by then
exposing the cells to a solution containing KSCN  (in mM: KSCN 110, MgSO4 1, HEPES 10, CaSO4 
1, glucose 5 and 5 µM valinomycin). For data analysis, the value for minimal fluorescence was
subtracted from the experimentally measured fluorescence and the resulting fluorescence divided by
the value of F0. The rate of Cl- efflux was determined by linear regression analysis of 30 points taken
at 2 second intervals and expressed in arbitrary slope changes in ∆(F/F0)/min. To calculate aiCl, a
calibration procedure was performed as per Brochiero et al. (26).
Measurements of transepithelial short-circuit current and chloride transport
Measurements of transepithelial potential difference (mV) and short circuit current (µA/cm2) 
were performed in a modified Ussing chamber according to published methods (28). Transepithelial
resistance (& x cm2) was calculated according to Ohm’s law. The electrical parameters were measured
at room temperature in the following Ringer solution (in mM): NaCl 110, MgSO4 0.5, KCl 3, KH2PO4 
1, Hepes 10, Glucose 5, CaCl2 1 (pH=7.5). As amiloride sensitive sodium channels have been shown
in A6 cells to contribute to Isc, chloride transport experiments were conducted in the presence of 10
µM of the sodium channel blocker, amiloride. 
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Protein extraction and Western blotting.
Total cellular lysates and crude membrane fractions were prepared and their protein content
measured as previously described (29). An aliquot of 50 µg protein was separated in 7% SDS-PAGE.
The separated proteins were transferred to Immobilon P (Millipore, DuPont) in a Trans-Blot semidry
electrophoretic transfer cell (Bio-Rad) for immunoblotting. Immunocomplexes were detected with
ECL reagent (Amersham). The following antibody was used: anti CFTR monoclonal antibody against
the carboxyl-terminus (R&D Systems, MAB25031, dilution 1:1000). In the cell lysate this antibody
recognizes two bands of approximately 175 kDa and 205 kDa (see Figure 3). 
Biotinylation of apical membrane proteins
To further characterize the molecular weight and expression levels of the form of CFTR located
in the apical membrane, apical cell surface biotinylation experiments were performed. A6 and A6-
NHE3 cells were grown on 60-mm Petri dishes and at confluence were washed with ice-cold Ringer
NaCl and incubated with 2 mg/ml sulfo-NHS-biotin in Ringer NaCl for 30 min at 4°C. Free sulfo-
NHS-biotin was blocked by washing cells twice at 4°C with 0.1 M glycine in  Ringer NaCl and then
with ice-cold Ringer NaCl. Cells were lysed in buffer lysis (0.4% sodium deoxycholate, 1% Igepal
CA-630 (SIGMA), 50 mM EGTA, 10 mM Tris-HCl pH 7.4 plus protease inhibitor cocktails)
centrifuged for 10 min (13,000 x g) and the pellet was discarded. 30 µl of Streptavidin-agarose beads
was added to the lysates (500 µl) and the mixture was incubated with gentle mixing at 4°C overnight.
Streptavidin-bound complexes were pelleted (13,000 x g) and washed three times with 500 µl of lysis
buffer. Biotinylated proteins were eluted in Laemmli buffer by boiling for 10 min, resolved by SDS-
PAGE, elettroblotted onto Immobilon-P, and immunoblotted with the C-terminal -CFTR antibody
(1:1000 dilution).
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Pull-down  Experiments
The GST-NHERF-1 and GST-NHERF-2 fusion protein homogenates were obtained and the
experiments were performed as previously described (29). In brief, equal amounts of GST-NHERF-1
and 2 fusion proteins (≥ 2 µg) were incubated with 25 µl of pre-equilibrated glutathione-agarose beads
(Sigma G-4510, 50% slurry) in a total volume of 500 µl of binding buffer (50 mM Tris-HCl, pH 8,
120 mM NaCl, 0.5% Igepal, 5 mM dithiothreitol), by rocking at 4°C for 1 h. After absorption, beads
were collected by brief centrifugation at 12,000 rpm for 10 sec (4° C) and gently washed three times
with 500 µl of binding buffer containing 0.075% SDS. Pull-down experiments were performed by
incubation of these beads with total cellular lysate from A6 and A6-NHE3 cells. 
Cellular lysates were prepared from 100 mm-diameter confluent plates. Cells were washed,
scraped using 1 ml of binding buffer (50 mM Tris-HCl, pH 8, 120 mM NaCl, 0.5% Igepal-CA-630
and then subjected three times to pulsed sonication for 30 sec on ice. Aliquots were cleared at 12,000
rpm for 2 min (4°C) and ≈ 3 mg protein of these lysates were incubated for 1 h at 4°C with GST-
NHERF (1 and 2) immobilized beads. The samples were then washed three times: firstly, with 500 µl
of binding buffer without SDS, secondly with 500 µl of binding buffer, diluted 1:2 with same buffer
without detergent and, finally, with 500 µl of binding buffer further diluted 1:2. The resulting pellet
was extracted in Laemmly buffer and used for SDS-PAGE electrophoresis. Western blotting was
performed with either the monoclonal anti-human CFTR antibody directed against the C-terminus or a
monoclonal anti-human Ezrin antibody (BD Transduction Laboratories) or the anti-rat NHE3 antibody
1568 (gift of Prof. O. W. Moe, Univ. Texas) obtained as described (30), and immunoreactive bands
were detected by ECL using a secondary HRP-coupled IgG (Sigma A-8924).
Antisense Oligodeoxynucleotide (ODNs) Treatment 
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A 21 mer phosphorothioate-modified antisense (AS) ODN complementary to the 5’ end of the
open reading frame of X. laevis CFTR was produced (5’-CTCCAGCGGCGTCTTCTGCAT-3’). A
corresponding missense (MS) ODN sequence (5’-ACGCTGGCTCTACGTTCGCTC-3’) was used as
control. ODNs, phosphorothioated for stability on the first 5 and last 5 nucleotides and purified by
HSFP, were purchased from MWG Biotech. A synthetic cationic lipid (Lipofectamine, Boehringer
Mannheim) was used to increase uptake and stability of the ODNs. AS or MS ODNs were added to the
complete culture medium of cell monolayers at final concentrations of 10 µM ODN and 13 µM
Lipofectamine for 5 hrs, at which time the growth medium was replaced. At 48 hrs post-treatment,
cells were collected for Western Blot analysis of CFTR expression and the cells were assayed for
transport activity. 
Data presentation
Results are presented as mean ± SE. Statistical comparisons were made using the paired and
unpaired data Student’s t  test and p< <0.05 was considered statistically significant.
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Results 
A6 cells, a cell line derived from the distal part of the nephron of the toad (Xenopus laevis), are
known to have transporters for both electrogenic sodium uptake and for electrogenic chloride secretion.
Patch-clamp experiments in A6 cells have demonstrated the presence of two types of apical Cl- 
channels which are controlled by calcium and/or cAMP (17). In addition, Ling et al. (19) have
demonstrated the existence of the chloride channel, CFTR, on their apical membrane.
We first validated the functional presence of CFTR on the apical membrane of the A6 cells and
the basic mechanism of its PKA-dependent up-regulation. CFTR activity was measured by two
parallel and independent techniques: via measurements of 1) transepithelial short circuit current, Isc, or
2) the efflux of chloride across the apical membrane measured by changes in fluorescence of the
chloride sensitive dye, MQAE. A6 cells grown on permeable filters formed a polarized monolayer
displaying a high transepithelial resistance (8400 ± 600 & x cm2, n=22). In all Isc experiments,
amiloride (10 µM) was present in the apical bath solution to inhibit electrogenic Na+ absorption. Under
these conditions cAMP stimulated Isc is referable to Cl- secretion. Figure 1 shows that the basolateral
application of 10 µM forskolin (FSK) elicited a rapid increase in the Isc. The subsequent apical addition
of glibenclamide, a well known inhibitor of CFTR (31), significantly inhibited the FSK-dependent Isc
increase (-53.5 ± 4.6%, n=6, p<0.01). On the other hand, DIDS (100 µM), a stilbene derivative known
to inhibit other anion transporters but not CFTR (32), did not inhibit the forskolin-stimulated Isc (-
0.71 ± 20.1%, n=5, n.s.). Further support for the hypothesis that FSK induced Cl- secretion was
derived from experiments in which the response to FSK was examined during perfusion of both sides
of the epithelium with Cl--free Ringer solution. Substitution of chloride with nitrate strongly reduced
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the FSK-dependent Isc increase obtained in the presence of chloride by 88.9 ± 0.5% (n=3). In the
histogram reported in Figure 1, glibenclamide-sensitive chloride transport (ie. CFTR-mediated
chloride transport) is indicated as the clear bar and was calculated as the difference of FSK-stimulated
Isc in the absence (light gray bar) and presence (dark bar) of glibenclamide.
Figure 2 illustrates a typical experiment and the summary of 9 experiments of apical chloride
efflux. After substitution of chloride by nitrate in the apical perfusion medium (see experimental
procedures), the rate of chloride efflux was measured by the change in fluorescence (∆(F/F0)/min) of
the chloride sensitive dye, MQAE, as described (25). As also observed in the same cell line by
Banderali et al. (25), a small amount of basal Cl- efflux occurred under baseline conditions when the
chloride solution was replaced by the nitrate solution (0.025 ± 0.007 ∆(F/F0)/min, n=9). Subsequent
FSK (10 µM) treatment of the same monolayer increased the chloride efflux rate and glibenclamide
added apically before the next stimulation with FSK significantly inhibited this chloride transport. In
the histogram of Figure 2, the clear bar represents the glibenclamide-sensitive Cl- efflux (CFTR-
mediated chloride transport) calculated from the difference in alterations of forskolin-stimulated
fluorescence measurement in the absence (light gray bar) and presence (dark bar) of glibenclamide.
The Na+/K+/2Cl- cotransporter, which is responsible for chloride loading of the cells, has been
demonstrated to be stimulated by cAMP (33). In the experiments summarized in Figure 2, we treated
the basolateral side of the monolayer with bumetanide (5 µM) for five minutes before each stimulation
with FSK to avoid the possibility that the observed increase of chloride efflux induced by FSK could be
due in part to the stimulation of the Na+/K+/2Cl- cotransporter. However, the glibenclamide-sensitive
chloride transport obtained in presence of bumetanide was not significantly different from that obtained
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in a parallel series of experiments in which we did not pretreat the cells with bumetanide
(glibenclamide sensitive Cl- efflux: 0.0202 ± 0.002 (F/F0)/min, n=7 vs 0.0169 ± 0.002 (F/F0)/min,
n=9 n.s, in the absence or presence of bumetanide, respectively).
Influence of NHE3 on CFTR activity
The ability of active CFTR to influence the PKA-dependent regulation of NHE3 activity in
fibroblasts co-transfected with CFTR and NHE3 via coupled interaction of the two transporters with
NHERF has been recently reported (7) and, thus, it could be hypothesized that NHE3 can affect CFTR
regulation. We, therefore, next examined whether there exists the reciprocal modulation by NHE3 on
PKA-dependent regulation of CFTR activity. To accomplish this, we utilized A6 cells stably
transfected with cDNA encoding the rat subtype of NHE3 (A6-NHE3 cells). As previously reported,
the transfected NHE3 is expressed on the apical membrane and is inhibited ( -38.14 ± 2.72, n=6
p<0.001)  by stimulation of PKA with forskolin (20).
We first determined if expressing NHE3 alters the expression of CFTR. As can be seen in a
typical Western Blot (Figure 3A), two bands of approximately 175 kDa (arrowhead) and 205 kDa
(arrow) were observed in the total cellular lysate while only the 205 kDa band was observed in either a
membrane fraction or in the streptavidin-precipitate of the biotinylated apical cell surface proteins. To
demonstrate that the anti-C-terminus antibody utilized in the experiments is specific for the CFTR in
A6 cells, we immunoprecipitated CFTR from cell lysate as described by Ling et al. (19) with a different
antibody (against the regulatory domain, R&D Systems, MAB1660) and Western analysis performed
with the above carboxyl-terminus antibody recognized the same two proteins (Figure 3B). These data
would suggest that the 175 kDa band could represent the immature, intracellular form and the 205 kDa
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band represents the mature CFTR. In order to further validate that the upper band corresponds to
mature CFTR, we deglycosilated crude membrane fractions with either Endoglycosidase H or N-
Glycosidase F since mature CFTR has been demonstrated to be resistant to Endoglycosidase H
deglycosilation but sensitive to N-Glycosidase F deglycosylation (34) and we observed that the band
was indeed unaffected by Endoglycosidase H and reduced in molecular weight by N-Glycosidase F
treatment (Fig. 3C). Further data to support this hypothesis came from experiments in which expression
of only the 205 kDa band was reduced by blocking the ER-to-Golgi traffic with 1µg/ml brefeldin A
(data not shown), a treatment that blocks the maturation of CFTR (35). As can be seen in Figure 3A,
the expression of NHE3 did not affect the expression of either the mature CFTR (arrow) or of the
immature, non-glycosylated CFTR (arrowhead). CFTR band intensity in A6-NHE3 cells was 95 ± 4%
of that in A6 cells in blots quantitated by densitometric analysis., n=7, n.s.). 
We next examined the effect of NHE3 expression on the PKA-regulated activity of CFTR by
comparing the effect of FSK (10 µM) on both the amiloride sensitive Isc (chloride secretion) in the
absence or presence of glibenclamide (Fig. 4A) and the glibenclamide-sensitive chloride efflux across
the apical membrane  measured by changes in fluorescence of the chloride sensitive dye, MQAE (Fig.
4B). It can be seen that in both types of measurements the apical expression of NHE3 in A6-NHE3
cells reduced the glibenclamide-sensitive chloride efflux by approximately 60%. The basal chloride
efflux in A6-NHE3 cells was not significantly different from that measured in A6 cells (0.0164 ±
0.005 (F/F0)/min, n=8 in A6-NHE3 vs 0.025 ± 0.007 ∆(F/F0)/min, n=9 in A6; n.s) and importantly,
there was no difference in intracellular chloride concentration between A6 and A6-NHE3 cells loaded
with MQAE (24.5 ± 2.4 vs 27.7 ± 4.1 mM, in A6, n=18, and A6-NHE3, n=11, cells, respectively). 
Moreover, the expression of NHE3 on the apical membrane raised the resting pHi from 7.22 ±
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0.09 (n=8) in A6 cells to 7.64 ± 0.09 (n=6) in A6-NHE3 cells (p < 0.01). Cellular alkalinization has
been shown to favour the stimulation of CFTR by cAMP (36) suggesting that it is not the effect of
NHE3 activity on cytosolic pH that mediates its observed negative effect on forskolin-stimulation of
CFTR in the A6-NHE3 cells. Altogether, these data clearly indicate that it is the presence of functional
NHE3 that negatively modulates (ie. decreases) the PKA-dependent regulation of CFTR.
In order to evaluate if the site of integration of the exogenous DNA for rat NHE3 could account
for the observed ‘interaction’ between NHE3 and CFTR, we transfected A6 cells with another subtype
(opossum) of the NHE3 isoform (A6-NHE3OK) (37). Indeed, the negative modulation of PKA-
dependent regulation of CFTR activity by the presence of NHE3 was confirmed in this cell line: neither
the amount of PKA-dependent inhibition of NHE3 activity (45.24 ± 2.65%, n=4, A6-NHE3OK vs
38.14 ± 2.72%, n=6, in A6-NHE3 cells, respectively) nor the value of the CFTR-mediated Cl- efflux
(0.0086 ± 0.009, n=6 in A6-NHE3OK vs 0.0078 ± 0.006 (F/F0)/min, n=7, in A6-NHE3) were
significantly different in A6 cells transfected with the opossum or rat subtype of the NHE3 isoform.
These data further support that the presence of functional NHE3 negatively modulates (ie. decreases)
the regulation of CFTR activity by PKA.
While the mechanism by which PKA phosphorylation of NHE3 leads to its inhibition is still
unknown, it is clear that this phosphorylation is necessary for its functional regulation (38). A critical
question in the context of the current study is if the PKA-dependent phosphorylation of NHE3 is
necessary for its modulation of PKA-induced CFTR regulation. To this purpose, we analyzed the
CFTR-dependent apical secretion in transfected A6 cells with rat NHE3 in which either of the PKA
target serines 552 or 605 was mutated to alanine (37). Previous studies, in fact, have demonstrated that
these two serines are PKA phosphorylation substrates in rat NHE3 and are necessary for its PKA
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dependent regulation (38 ,39 ,40). We found that both the S552A and S605A mutations completely
reversed the FSK inhibitory effect on NHE3 activity (respectively in the absence and presence of FSK:
0.275±0.04 vs 0.265±0.4 pHi/min in A6-NHE3S552A, n=6 n.s and 0.394±0.046 vs 0.402±0.05
pHi/min in A6-NHE3S605A, n=4, n.s.). As illustrated in Figure 5A, the expression of membrane
CFTR did not change in any of these transfected cell lines. The cell monolayers with the mutated
NHE3 were then stimulated with forskolin and CFTR-dependent apical chloride efflux analyzed by
fluorescence measurements as in Figure 2. Figure 5B shows that when PKA can no longer
phosphorylate either of these two serines, the regulation of CFTR activity by forskolin returned to
levels not significantly different from that observed in the wild-type A6 cells. These results
demonstrate that endogenous NHE3 phosphorylation by PKA is an absolute requirement for its
modulation of PKA-dependent regulation of CFTR. Altogether, these data imply that the PKA-
dependent regulation of CFTR but not its expression is negatively modulated by functional NHE3. 
Inhibition of CFTR expression results in a decrease of the PKA-dependent regulation of apical NHE3
activity. 
As we found a negative modulating effect of NHE3 expression on PKA-dependent regulation
of CFTR activity, we felt it necessary to validate the positive effect of CFTR on NHE3 regulation that
was previously demonstrated in fibroblasts (7) in the A6-NHE3 cells which express CFTR
endogenously on the apical membrane. Inhibition of CFTR expression by an antisense oligonucleotide
(ODN) against the CFTR start site has been previously utilized in cells expressing endogenous CFTR
to demonstrate that CFTR modulates the activity and regulation of the ENaC sodium channels (19).
Based on these observations, we synthetized a 21 mer antisense ODN or its missense against the
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 Xenopus laevis CFTR start site in order to confirm the occurrence and pattern of modulation of the PKA-
dependent regulation of apical NHE3 activity by endogenous, apically located CFTR. Incubation of
A6-NHE3 cells with 10 µM of antisense for 48 hrs led to a marked reduction of both CFTR protein
expression (Fig. 6A) and of the forskolin-dependent stimulation of CFTR activity (the mean reduction
of the CFTR chloride efflux by antisense treatment was -49.4 ± 2.8%, n=3, p< 0.02). This is a slightly
higher level of inhibition of CFTR activity by the antisense ODN treatment than that reported by Ling
et al. (19). 
We then determined the effect of this missense and antisense treatment on the PKA-dependent
regulation of the apical NHE3 in the A6-NHE3 cell line. As can be seen in Figure 6B, this antisense-
induced reduction in CFTR expression had no effect on basal transfected, apical NHE3 activities
(controls, solid bars) but resulted in an almost complete loss of the forskolin-dependent regulation of
the NHE3 activity while, in the missense transfected cells (MS-CFTR), forskolin inhibited the NHE3
to almost the same level as in the non-transfected cells. These results confirm the reported modulatory
effect of CFTR on NHE3 regulation by PKA in a highly polarized cell line that endogenously expresses
CFTR.
Role of NHERF-2 in the reciprocal PKA-dependent regulation of CFTR and NHE3 activity.
It has been demonstrated that both NHE3 and CFTR can associate with either the NHERF-1
(11,41) or the NHERF-2 (14) isoform. In the renal cortical collecting duct the NHERF-2 isoform is
more strongly expressed (42), suggesting that in the A6 cells NHERF-2 could be the relevant isoform.
We therefore examined, via GST-fusion protein pull-down assays, the association of these two
NHERF isoforms with CFTR and NHE3 in the A6 and A6-NHE3 cell lines. Figure 7 shows that,
indeed, CFTR (Fig. 7A) was pulled-down from total cellular lysate by NHERF-2 but not NHERF-1 in
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both cell lines. It is noteworthy that, although both mature and immature CFTR are present in the lysate
(see Fig. 3), only the immature form was pulled-down by NHERF-2 (see arrowhead). Similar
experiments performed in A6-NHE3OK cells confirmed that the low molecular weight, immature form
of CFTR associates preferentially with NHERF-2 (data not shown). 
As can seen in Fig. 7B, NHE3 was pulled-down by only NHERF-2 and only in the A6-NHE3 cell
line. In brush border membrane fractions from rat kidney, used as positive controls, NHE3 was also
recognized almost exclusively by the NHERF-2 fusion protein. 
The NHERF directed PKA phosphorylation of target proteins has been demonstrated to be
mediated by the association of the AKAP protein, ezrin, to NHERF in a wide variety of cell contexts
(14,43). In order to determine if ezrin forms a part of this signaling complex in our cell model, we
probed NHERF-1 and NHERF-2 pull-downs with an anti-ezrin antibody. Indeed, as can be seen in
Figure 7C, ezrin was found to associate with the two NHERF isoforms in both cell lines. 
Role of the AKAP protein ezrin in the reciprocal PKA-dependent regulation of CFTR and NHE3
activity.
Recent work has demonstrated that A-kinase anchoring proteins (AKAPs) play a fundamental
role in governing the cellular compartimentalization of PKA in order to localize it in proximity of the
target substrate. This appears to be due to the binding of the regulatory PKA subunits RII to the AKAPs
at a specific amino acid consensus sequence that can be blocked by the synthetic peptide Ht31 (44).
Recently, it has been demonstrated that PKA associates with CFTR by the AKAP protein, ezrin (45).
To determine if PKA-dependent regulation of CFTR is mediated by anchorage to an AKAP in our cell
models and how this is altered by the presence of NHE3, we preincubated monolayers of either A6 or
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A6-NHE3 cells for 30 minutes with Ht31, an amphipathic peptide that corresponds to the RII binding
motif of a human thyroid AKAP (46) or with its inert analog, Ht31-P containing prolines at positions
502 and 507 (47) and measured the PKA-dependent stimulation of CFTR-dependent chloride efflux in
both cell lines and inhibition of NHE3 in the A6-NHE3 cell line. We have used Ht31 and Ht31-P
coupled to stearate residues (S-Ht31 and S-Ht31-P) and thus rendered membrane-permeable (47). As
can be seen in Figure 7, preincubation with S-Ht31 almost completely eliminated forskolin-dependent
stimulation of apical CFTR-dependent chloride transport in A6 cells. In contrast, S-Ht31 treatment
had no effect on the CFTR-dependent efflux in the A6-NHE3 cells (Fig.8) while it completely
prevented the PKA-dependent inhibition of NHE3 (Fig. 9). The inert analogue, S-Ht31-P, had no
effect on the PKA-dependent regulation of either CFTR (Fig. 8) or NHE3 (Fig. 9) transport activity.
The fact that Ht31 did not affect forskolin-mediated activation of CFTR in A6-NHE3 cells suggests
that when NHE3 is coexpressed with CFTR the protein complex ezrin-NHERF2 might anchor the
Type II regulatory subunits of PKA (PKA II) in proximity to NHE3. In this way the residual forskolin
activation of CFTR could regulated predominantely by the cytosolic, non-anchored Type I PKA. Singh
et al. (48) have reported that CFTR can be regulated by both Type I and II PKA in T84 cells. In support
of this hypothesis, we found that 10 µM of the pan-specific PKA inhibitor, H89, was able to almost
completely inhibit the CFTR-dependent chloride efflux in A6-NHE3 cells by 86 ± 6% (n=4, p<0.001).
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Discussion
In addition to transepithelial chloride transport, CFTR has been shown to influence a
large number of cell functions including the transport of other electrolytes (3). By influencing these
electrolyte transports it appears that CFTR plays a fundamental role in regulating cell content and
volume of fluids. As a modulator of transepithelial sodium transport, CFTR has been demonstrated to
play a modulating role in the PKA-dependent regulation of the activity of both sodium channel
(ENaC) (49) and Na+/H+ exchanger isoform 3 (NHE3) (7). The mechanism underlying the PKA-
dependent regulation of NHE3 involves direct interaction with PDZ-containing scaffolding proteins
such as the NHERF in which the NHERF can function to link NHE3 with ezrin, a protein kinase A
anchoring protein, creating a multi-protein complex and, thereby, mediating the PKA-dependent
regulation of NHE3 (10,43,50). There is evidence demonstrating that either NHERF isoform can also
associate with CFTR via the PDZ1 domain (12,41) to confer, via direct, ezrin-mediated
phosphorylation, PKA-dependent regulation of its activity (14). 
This co-ordination of PKA-dependent regulation of either NHE3 or CFTR in the apical plasma
membrane of epithelia by NHERF suggests a mechanism by which CFTR could regulate the NHE3
through the joint association with NHERF. Indeed, it has been recently demonstrated, by co-
transfection of NHE3 and CFTR in fibroblasts, that CFTR modifies the PKA-dependent regulation of
NHE3 via interaction with the NHERF-1 isoform (7). Conversely, the joint interaction of CFTR and
NHE3 with NHERF suggests the existence of a reverse, reciprocal modulating effect of NHE3 on
CFTR regulation. Along this line, recent work examining the relationship between CFTR and ENaC
sodium channels demonstrated such a reciprocal interaction between CFTR and ENaC: CFTR not only
acts as a regulator of ENaC but is, in turn, regulated by ENaC (51).
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In the present study, we have considered the possibility of the existence of a potential reciprocal
modulation of PKA-dependent regulation of CFTR by NHE3. In order to study this reciprocal
interaction between CFTR and NHE3 in a highly polarized monolayer, we used a cell line expressing
an endogenous CFTR (19) and a transfected rat NHE3 on the apical membrane (20). CFTR and ezrin
associated with NHERF-2 in both cell lines and NHE3 associated with NHERF-2 in the A6-NHE3
cell line (Fig. 7). In these cell lines, we verified that in CFTR antisense-treated A6-NHE3 monolayers,
forskolin was no longer able to inhibit the NHE3 activity. These data confirm that CFTR is required for
the PKA-dependent inhibition of Na+ absorption driven by NHE3 as reported in both heterologous
double transfected fibroblasts (7) and in mouse intestine (52) and support the hypothesis that CFTR and
NHE3 could interact via a common regulatory scaffold protein.
The most significant finding of the present study was that the PKA-dependent regulation of
CFTR is also, in turn, negatively modulated by the presence and activity of NHE3. The PKA-
dependent regulation of CFTR-mediated Cl- secretion was lower in A6-NHE3 than in A6 cells
without a change in either CFTR protein expression (Fig. 3) or association of CFTR with NHERF-2
(Fig. 7). The same pattern of modulation of the PKA-dependent regulation of CFTR-mediated Cl-
 secretion by NHE3 expression and association of CFTR with NHERF-2 was observed in an A6 cell line
that had been stably transfected with the opossum subtype of NHE3 (A6-NHE3OK). 
The mutation of either of the two PKA phosphorylation substrate serines, 552 or 605, to alanine
(40) prevented the forskolin-induced inhibition of NHE3 and significantly relieved the negative
modulating effect of NHE3 on PKA-dependent regulation of CFTR activity without a change in CFTR
expression (Fig. 5), demonstrating that it is not the presence of NHE3 but the phosphorylation by PKA
that is required for the negative influence of NHE3 on CFTR regulation. All together, the data suggest
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either that NHE3 has a higher affinity for associating with the regulatory NHERF-ezrin-PKA complex
or that CFTR functions to direct PKA-dependent regulation to NHE3 when the two transporters are
functionally co-expressed. That is, when only CFTR is expressed it is the substrate for the NHERF-
ezrin-PKA complex while when NHE3 is co-expressed, CFTR becomes a component in a new
complex for NHE3 regulation as was previously suggested (7). This could explain how CFTR can
function either as a PKA-regulated chloride channel or as a transmembrane regulatory protein for other
transporters: it is the relative expression of the various components of this regulatory module that
determines which function CFTR will have. A significant confirmation for this hypothesis came from
the experiments in which we pretreated A6 and A6-NHE3 cells with S-Ht31 which prevents the
binding between AKAPs and Type II regulatory subunits of PKA (47). Indeed, S-Ht31 interfered with
the PKA-mediated activation of CFTR in A6 cells, suggesting that the PKA-CFTR interaction is
mediated by an AKAP as recently was observed in Calu-3 airway cells (45). In the A6-NHE3 cells,
S-Ht31 completely blocked the forskolin-mediated inhibition of NHE3 activity (Fig. 9) while it was
no longer able to block the activation of CFTR chloride efflux by forskolin (Fig. 8), suggesting that the
co-expression of NHE3 led to the targeting of the multiprotein complex ezrin-PKAII-NHERF-2 to
the proximity of NHE3 rather than to CFTR. 
A possible complementary mechanism for this last hypothesis could be that an interaction
between CFTR and both of the two PDZ domains of NHERF-2 is needed for the PKA-dependent
increase in CFTR activity. Recently, Raghuram et al. (53) demonstrated that NHERF binds to the
cytoplasmic tail of CFTR through either of its two PDZ domains although with a higher affinity for the
PDZ1 domain. The association of CFTR with both domains regulated channel gating by crosslinking
the C-terminal tails in a single dimeric CFTR channel which resulted in an increase in the open
probability. In this model, when NHE3 binds to one of the PDZ domains of NHERF, CFTR is no
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longer able to be in the dimeric form and thus loses part of its PKA-dependent regulation. A
configuration of dimeric CFTR would give rise to more active channels when activated by PKA, thus
modulation of the intermolecular CFTR interaction is an attractive mechanism for the potentiation of its
activity by PKA (54). The same mechanism was recently demonstrated for the adapter protein, CAP70
(55), in which the CFTR channel is switched to a more active conductive state via an interaction with
the two CAP70 PDZ domains, suggesting that this mechanism is widespread.
In conclusion, the novel finding of this study was that there is a reciprocal interaction between
CFTR and NHE3 for PKA-dependent regulation. To determine the precise mechanism whereby NHE3
co-expression influences the regulation of CFTR by PKA will require further investigation. Thus,
NHE3, like ENaC, is not simply a passive recipient of CFTR regulatory action but plays an active role
by altering, in turn, CFTR function. 
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Figure Legends
Figure 1. A) Typical time course of short-circuit current (Isc) and transepithelial potential difference
(∆V) during stimulation with 10 µM basolateral forskolin (FSK) in the absence or presence of apical
glibenclamide (300 µM). The measurements were always conducted in the presence of 10 µM
amiloride to block the apical sodium channels. The increase of FSK-dependent Isc was significantly
diminished by glibenclamide applied on the apical side. B) Summary of this inhibitory effect in a series
of 6 experiments. The empty bar represents the CFTR-dependent component of the transepithelial Isc
calculated as the difference of the amiloride-independent, forskolin-stimulated increase in Isc in the
absence of (light gray bar) and presence of (dark bar) glibenclamide. Each bar represents the mean ± 
S.E. of paired measurements. 
Figure 2. A) Typical recording showing changes in intracellular Cl--dependent MQAE fluorescence
(expressed as the F/F0 ratio) when the A6 cell monolayer was treated with 10 µM FSK following
substitution of apical chloride by nitrate in the absence or presence of glibenclamide (300 µM).
Glibenclamide was applied for five minutes before apical anion substitution. The basolateral side was
perfused with a chloride solution containing 5 µM bumetanide for 5 minutes before each stimulation
with FSK to block the cAMP sensitive basolateral Na+/K+/2Cl- cotransporter.  B) Summary of these
data from 9 independent experiments where the glibenclamide-sensitive Cl- efflux rates across the
apical membrane (empty bar) were calculated as the difference in the F/F0 ratio per minute
((F/F0)/min) in the absence of (light grey bar) and presence of (dark bar) glibenclamide. Each bar represents
the mean ± S.E.. In the same monolayer we first followed the rate of Cl- efflux after forskolin
treatment and then always in the same monolayer we analyzed the effect of glibenclamide; this
permitted the use of two-tailed, paired Students t-test analysis of the data.
Figure 3. Stable expression of rat NHE3 has no effect on CFTR expression.  A) Total cellular lysates,
crude membrane fractions or a streptavidin-precipitate of biotinylated apical membrane proteins were
prepared from A6 and A6-NHE3 cells, separated by 7% SDS-PAGE and blotted onto Immobilon-P
for Western Blot analysis with monoclonal antibody against the CFTR C-terminus. The position of the
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mature, glycosylated and the immature, core form of CFTR are indicated by an arrow and an
arrowhead, respectively. B) CFTR was immunoprecipitated from A6 cell lysate with an antibody
against the regulatory domain (R&D Systems MAB1660) and Western analysis performed with an
antibody against its carboxyl-terminus (R&D Systems MAB 25031). C) Crude membrane fractions
from A6 and A6-NHE3 cells were digested as described in Experimental Procedures with either
Endoglycosidase H or N-Glycosidase F.
Figure 4. Stable expression of rat NHE3 decreases cAMP-mediated activation of CFTR chloride
transport.  A) The glibenclamide-sensitive components of the forskolin-stimulated, amiloride-
insensitive Isc in A6 and A6-NHE3 cells were calculated as in Figure 1. Data are mean ± S.E. for 6
and 4 unpaired experiments, respectively.  B) The glibenclamide-sensitive Cl- efflux rates in A6 and
A6-NHE3 cells were calculated as in Figure 2. Data are mean ± S.E. for 9 and 7 unpaired experiments,
respectively.
Figure 5. PKA-dependent phosphorylation of NHE3 is necessary for modulation of cAMP-mediated
activation of CFTR chloride transport. A) Expression of CFTR in crude membrane extracts from all
four cell lines measured by Western Blot as in Figure 3. B) The glibenclamide-sensitive chloride efflux
was measured as in Figure 2 in A6, A6-NHE3, A6-NHE3S552A and A6-NHE3S605A cell lines.
Data are mean ± S.E. of 9, 7, 4 and 7 unpaired experiments, respectively. 
Figure 6. CFTR antisense but not missense treatment reduced CFTR expression and prevented cAMP-
mediated inhibition of NHE3 activity in A6-NHE3 cells. Monolayers were transfected with 10 µM
antisense or missense ODN complementary to the 5′ end open reading frame start site of X. laevis
CFTR and, 48 hrs later, the expression of CFTR and measurement of NHE3 activity measured.
Antisense but not missense treatment A) depleted the expression of CFTR in whole cell lysates
measured by Western Blotting as in Figure 3 and B) led to a reversal of the forskolin-dependent
inhibition of apical NHE3 activity measured by monitoring changes in fluoresence of the pHi sensitive
dye, BCECF, as described in Experimental Procedures. Data are mean ± S.E. for 6, 5 and 4 paired
experiments for control, missense and antisense, respectively.
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Figure 7. CFTR and NHE3 are recognized by NHERF-2 but not NHERF-1 in GST pull-down. Total
cell lysates from A6 and A6-NHE3 cells were prepared and pull-down experiments conducted as
described in Experimental Procedures. A) A typical Western Blot for CFTR is shown in which lanes 1
and 2 are total cellular lysates, lane 3 is A6 cell lysate incubated with GST-alone, lanes 4 and 5 are
extracts of the GST-NHERF-1 pellet of A6 and A6-NHE3 lysates and lanes 6 and 7 are extracts of the
GST-NHERF-2 pellet of A6 and A6-NHE3 lysates. As in Figure 3, the position of the mature,
glycosylated and the immature, core form of CFTR are indicated by an arrow and an arrowhead,
respectively. B) An analogous experiment in which the blot was probed with a polyclonal antibody
against rat NHE3. As positive control, the GST-NHERF-1 and GST-NHERF-2 pull-down
measurements were performed with brush border membrane derived from rat kidney. C) An analogous
experiment in which the blot was probed with a monoclonal antibody against ezrin.
Figure 8. The synthetic AKAP blocking peptide, S-Ht31, inhibits PKA-dependent stimulation of
CFTR chloride efflux in A6 but not A6-NHE3 cells. Cell monolayers were preincubated for 30 min
with 100 µM of the anti-AKAP peptide S-Ht31 or its inactive form S-Ht31-P and the effect of FSK
(10 µM) on CFTR activity was analyzed as in Figure 2. Data are mean ± S.E. for 9, 5 and 5 unpaired
experiments for control, S-Ht31-P and S-Ht31 in A6 cells and 7, 3 and 5 unpaired experiments for
control, S-Ht31-P and S-Ht31 in A6-NHE3 cells, respectively.
Figure 9. The synthetic AKAP blocking peptide, S-Ht31, inhibits PKA-dependent inhibition of NHE3
activity in A6-NHE3 cells. Cell monolayers were preincubated for 30 min with 100 µM of the anti-
AKAP peptide S-Ht31 or its inactive form S-Ht31-P and the effect of FSK (10 µM) on NHE3 activity
was analyzed as in Figure 5B. Data are mean ± S.E. for 7, 5 and 6 experiments for control, S-Ht31-P
and S-Ht31 experiments, respectively.  Experiments reported in this figure were carried out such that
control pHi recovery was performed first and then always compared to the pHi recovery after the
treatment performed on the same monolayer. This permitted the use of two-tailed, paired Students t-
test analysis of the data.
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